A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

TurboFil Introduces Inline Wrap Labeler for Dual Syringe Applications

TurboFil Packaging Machines LLC, an equipment specialist dedicated solely to the design and development of liquid filling and assembly machines, has introduced a wraparound labeler that automates the often complex, labor-intensive process of dual syringe cartridge labeling. The company’s In-line Dual Syringe Labeler reliably, repeatably and accurately affixes labels around one or both cartridges in two-syringe systems.

For added versatility, TurboFil’s new machine offers both a semi-wrap mode, which wraps around one of the two cartridges, or full-wrap mode, which encircles both. The In-line Dual Syringe Labeler is designed to handle 50ml 1:1 pre-filled plastic dual-chamber syringes, such as those used in dental impression materials, restoratives and adhesives. With a maximum labeling speed of 25 meters/min, the unit can process up to 30 dual cartridges per minute.

The In-line Dual Syringe Labeler largely automates the traditionally cumbersome manual process of wraparound labeling in dual-chamber syringe settings. A single operator places syringes nose-up on the eight-foot labeling conveyor, where cartridge sensors identify them. Syringes then proceed toward the module’s servo-controlled HERMA US label applicator, where they are supported from the top with a belt. Labels are tamped on, then wrapped around one or both syringe barrels before continuing along the conveyor to a collection bin.

Given its alternating semi- and full-wrap capabilities, TurboFil’s In-line Dual Syringe Labeler can handle an especially broad range of labeling parameters. It can apply labels from 12-160mm wide, and from 12-400mm in length. Its feeder handles label rolls 300mm in diameter. An optional thermal-transfer printer also is available.

“Among other applications, dual syringes are increasingly utilized for dental products such as impression materials, restoratives, whiteners and adhesives,” said Deborah Smook, VP of Marketing & Business Development for TurboFil Packaging Machines LLC. “Solutions that streamline their production are increasingly sought-after by pharma companies looking to maximize capacity without sacrificing quality. The In-line Dual Syringe Labeler reduces the manpower required for an historically labor-intensive process down to a lone operator, allowing manufacturers to reallocate personnel to other priorities.”

SourceTurboFil
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy